Erythromycin belongs to Biopharmaceutical Classification System (BCS) class 2, indicating limited solubility, which in turn results in restricted penetration and effectiveness.Incorporating erythromycin into a nanoemulsion delivery system can be a promising approach to overcome its limitations. This study aims to find the optimum formula for erythromycin nanoemulsion with variations in the conc…